Movatterモバイル変換
[0]
ホーム
URL:
画像なし
夜間モード
Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Community portal
Project chat
Create a new Item
Recent changes
Random Item
Query Service
Nearby
Help
Special pages
Lexicographical data
Create a new Lexeme
Recent changes
Random Lexeme
Search
Search
English
Appearance
Donate
Create account
Log in
Personal tools
Donate
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
natalizumab
(Q386119)
Item
Discussion
English
Read
View history
Tools
Tools
move to sidebar
hide
Actions
Read
View history
General
What links here
Related changes
Permanent link
Page information
Concept URI
Cite this page
Get shortened URL
Download QR code
Print/export
Create a book
Download as PDF
Printable version
In other projects
Appearance
move to sidebar
hide
From Wikidata
pharmaceutical drug
AN100226m
PB006
anti-alpha4 integrin
anti-VLA4
antegran
natalizumab-sztn
edit
Language
Label
Description
Also known as
default for all languages
No label defined
–
English
natalizumab
pharmaceutical drug
AN100226m
PB006
anti-alpha4 integrin
anti-VLA4
antegran
natalizumab-sztn
Statements
instance of
type of chemical entity
0 references
subclass of
protein
0 references
has use
medication
1 reference
title
Natalizumab
(English)
stated in
DrugBank
language of work or name
English
publication date
17 November 2015
DrugBank ID
DB00108
image of molecular model or crystal lattice model
Natalizumab 4IRZ.png
2,048 × 2,048; 155 KB
depicts
space-filling model
0 references
defined daily dose
10
milligram
route of administration
parenteral route of administration
1 reference
reference URL
https://www.whocc.no/atc_ddd_index/?code=L04AA23
active ingredient in
Natalizumab Elan Pharma
1 reference
European Medicines Agency product number
EMEA/H/C/000624
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000624/human_med_000919.jsp
retrieved
22 March 2017
Tysabri
1 reference
European Medicines Agency product number
EMEA/H/C/000603
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000603/human_med_001119.jsp
retrieved
22 March 2017
World Health Organisation international non-proprietary name
natalizumab
(English)
1 reference
stated in
ChEMBL
ChEMBL ID
CHEMBL1201607
language of work or name
English
title
Natalizumab
(English)
retrieved
19 January 2016
side effect
headache
0 references
fatigue
0 references
arthralgia
0 references
urinary tract infection
0 references
lower respiratory tract infection
0 references
gastroenteritis
0 references
vaginitis
0 references
mental depression
0 references
nausea
0 references
medical condition treated
secondary progressive multiple sclerosis
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
relapsing-remitting multiple sclerosis
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
multiple sclerosis
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
Crohn's disease
0 references
route of administration
intravenous infusion and defusion
0 references
legal status (medicine)
medical prescription
location
United States
start time
August 2023
applies to part
biosimilar
0 references
boxed warning
1 reference
reference URL
https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802
title
FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.
(English)
pregnancy category
Australian pregnancy category C
1 reference
imported from Wikimedia project
English Wikipedia
US pregnancy category C
1 reference
imported from Wikimedia project
English Wikipedia
has characteristic
biopharmaceutical
1 reference
title
Natalizumab
(English)
stated in
DrugBank
language of work or name
English
publication date
17 November 2015
DrugBank ID
DB00108
subject has role
immunologic factor
1 reference
stated in
Medical Subject Headings
MeSH descriptor ID
D000069442
retrieved
15 March 2018
monoclonal antibody
1 reference
stated in
DrugBank
DrugBank ID
DB00108
language of work or name
English
title
Natalizumab
(English)
publication date
17 November 2015
Identifiers
CAS Registry Number
189261-10-7
1 reference
stated in
DrugBank
DrugBank ID
DB00108
language of work or name
English
title
Natalizumab
(English)
publication date
17 November 2015
ChEMBL ID
CHEMBL1201607
1 reference
stated in
ChEMBL
ChEMBL ID
CHEMBL1201607
language of work or name
English
title
Natalizumab
(English)
retrieved
19 January 2016
HSDB ID
8174
1 reference
stated in
Hazardous Substances Data Bank
HSDB ID
8174
publication date
28 October 2019
title
Natalizumab
(English)
retrieved
10 May 2021
DSSTox substance ID
DTXSID90920506
0 references
ATC code
L04AA23
1 reference
stated in
DrugBank
DrugBank ID
DB00108
language of work or name
English
title
Natalizumab
(English)
publication date
17 November 2015
Guide to Pharmacology Ligand ID
6591
0 references
MeSH descriptor ID
D000069442
subject named as
Natalizumab
0 references
MeSH tree code
D12.776.124.486.485.114.224.060.813
0 references
D12.776.124.790.651.114.224.060.813
0 references
D12.776.377.715.548.114.224.200.813
0 references
RxNorm ID
354770
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148870
retrieved
26 February 2018
DrugBank ID
DB00108
0 references
UNII
3JB47N2Q2P
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148870
language of work or name
English
title
NATALIZUMAB
(English)
retrieved
19 January 2016
MedlinePlus drug identifier
a605006
0 references
PatientsLikeMe treatment ID
natalizumab
0 references
NDF-RT ID
N0000148870
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148870
language of work or name
English
title
NATALIZUMAB
(English)
retrieved
19 January 2016
DeCS ID
55977
0 references
Encyclopædia Britannica Online ID
topic/Natalizumab
subject named as
Natalizumab
0 references
Freebase ID
/m/06bl52
1 reference
stated in
Freebase Data Dumps
publication date
28 October 2013
Microsoft Academic ID
2781004633
0 references
2910384055
0 references
OpenAlex ID
C2781004633
1 reference
stated in
OpenAlex
retrieved
26 January 2022
reference URL
https://docs.openalex.org/download-snapshot/snapshot-data-format
UK Parliament thesaurus ID
512946
subject named as
Natalizumab
0 references
WikiProjectMed ID
Natalizumab
0 references
Sitelinks
Wikipedia
(22 entries)
edit
arwiki
ناتاليزوماب
cswiki
Natalizumab
dewiki
Natalizumab
enwiki
Natalizumab
eswiki
Natalizumab
fawiki
ناتالیزومب
frwiki
Natalizumab
hewiki
נטליזומאב
itwiki
Natalizumab
jawiki
ナタリズマブ
nlwiki
Natalizumab
orwiki
ନାଟାଲିଜୁମାବ
plwiki
Natalizumab
ptwiki
Natalizumab
ruwiki
Натализумаб
shwiki
Natalizumab
srwiki
Natalizumab
svwiki
Natalizumab
trwiki
Natalizumab
ukwiki
Наталізумаб
viwiki
Natalizumab
zhwiki
納他利珠單抗
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
Retrieved from "
https://www.wikidata.org/w/index.php?title=Q386119&oldid=2300677449
"
Search
Search
natalizumab
(Q386119)
Add topic
[8]
ページ先頭
©2009-2025
Movatter.jp
